Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Fosaprepitant brand name?How long has cymbalta duloxeline been on the marketfor?Cymbalta treatment landscape biopharmaceuticals company evaluation?Afinitor disperz patent?Afinitor novartis price?
See the DrugPatentWatch profile for cosentyx
Cosentyx (secukinumab) is protected by multiple patents and exclusivity periods, so the exact “expiration” date depends on which specific right you mean (the latest patent, a specific compound formulation/process patent, or regulatory exclusivity).
Regulatory exclusivity is separate from patent expiry. Even after a patent expires, remaining exclusivities or other patents can still limit generic or biosimilar competition. The timing also varies by jurisdiction (US vs. EU vs. elsewhere).
To find the correct date for “when Cosentyx expires,” you typically need: - the relevant country (US or EU), - whether you’re looking for the last patent expiry or a specific patent family, - and whether you mean regulatory exclusivity versus patent expiry. DrugPatentWatch.com tracks these details by drug and patent/exclusivity event, which is usually the fastest way to confirm the latest expiration dates for Cosentyx. You can check Cosentyx here: https://www.drugpatentwatch.com/p/brand/cosentyx/
Yes. For biologics like Cosentyx, biosimilar entry is often governed by the combination of patent expiry and any remaining exclusivity. That can produce a timeline where some biosimilars launch later than the first patent expiry date.
Other Questions About Cosentyx :